The polymorphic frequency of the gene for Bs-globin involved in the generation of sickle trait and sickle cell anemia in the human population is caused by the enhanced resistance of sickle trait individuals to Plasmodium falciparum malaria, as supported by epidemiologic and in vitro studies. However, the mechanism for the protective effect of sickle hemoglobin in vivo has not been fully defined. The generation of transgenic mice expressing high levels of human p-and a-chains has allowed us to study this phenomenon in vivo in an experimental model. We infected the transgenic Bs mice with two species of rodent malaria and found a diminished and delayed increase in parasitemia as compared with controls. This is in contrast to our previous stud-HE BASIS for the protection against Plasmodium fa/-T ciparum malaria afforded to heterozygous carriers of the gene for sickle hemoglobin (HbS) has been the subject of intense interest.' Early epidemiologic studies of Allison' and others3 indicated that the survival of sickle trait individuals infected with P falciparum malaria was enhanced. More extensive and recent have shown a reduction in the frequency and density of parasitemia. Early work by Luzzatto et a16 showed that the rate of sickling of parasitized AS (sickle trait) cells was twofold to eightfold greater than sickling in nonparasitized cells under completely deoxygenated conditions.
T ciparum malaria afforded to heterozygous carriers of the gene for sickle hemoglobin (HbS) has been the subject of intense interest.' Early epidemiologic studies of Allison' and others3 indicated that the survival of sickle trait individuals infected with P falciparum malaria was enhanced. More extensive and recent have shown a reduction in the frequency and density of parasitemia. Early work by Luzzatto et a16 showed that the rate of sickling of parasitized AS (sickle trait) cells was twofold to eightfold greater than sickling in nonparasitized cells under completely deoxygenated conditions.
Following the introduction of the continuous culture of P falciparum developed by Jensen and Trager,' the question of parasite survival within AS erythrocytes was reinvestigated. Roth et a1,8 complementing the observation of Luzzatto, 6 found that erythrocytes infected with P falciparum sickled faster than nonparasitized cells at physiologic venous oxygen tensions, both in the early (ring) as well as the late (schizont) stages of the parasite. The ability to manipulate the culture conditions led to studies by Friedman et al'," on the mechanism of protection afforded by AS cells. It was found that the pH of infected AA (normal) cells is 0. 4 of noninfected cells. This drop in pH is sufficient to cause sickling of the infected AS erythrocytes and potential trapping of the parasitized red blood cells (RBCs) by the spleen ("suicidal infection").
In vivo, P falciparum-infected erythrocytes undergo schizogony in the microcirculation of some organs (sequestration) because the late stages of the parasite adhere to venular endothelial cells.'','2 It is thought that the reduced oxygen tensions and lower intracellular pH present in these organs similarly leads to sickling of the RBCs and death of the parasites.' Nevertheless, the relative importance of the suicidal infection versus the interference with schizogony during sequestration has not been defined. and in vitro data6.*-'' that strongly suggest that HbS is protective against P falciparum, the availability of transgenic mice expressing Ps-globin allowed us to confirm and to extend these observations, providing a firmer basis for this innate resistance. Further, the use of this model allowed us to question the nature of this protection and the relative importance of the mechanisms proposed. Because the RBCs were from the mouse, we analyzed the course of the rodent malaria infections, Plasmodium chabaudi adami and Plasmodium berghei.
We observed that the PS transgenic mice were indeed protected from rodent malaria. In addition, we found that the spleen plays a dominant role in this protection in the ps transgenic mice.
Although there is ample

MATERIALS AND METHODS
A transgenic mouse line expressing both the human PS-and the human a2-globin genes, each separately linked to the P-globin locus control region, has been produced by pronuclear coinjection of the two transgenes. 13 The transgenic mice, originally produced using the normal inbred strain FVB/N, were subsequently bred to homozygosity for a deletion of the mouse &major globin gene, Hbbd3"h',14 carried on a C57BL/6J background. Mice with the &major globin gene deletion alone have a thalassemic phenotype but the transgene completely corrects this defect, as judged by mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration (MCHC), isopycnic gradient centrifugation, and hemoglobin (Hb) level^.^^.^^ The human a gene was used because the mouse achain inhibits the polymerization of HbS. In the resulting animals, approximately 72.7% f 2.4% of the P-globin chains were human PS,
Transgenic mice.
ps TRANSGENIC MICE RESIST RODENT MALARIA 223 and 44.7% * 2.4% of the a-chains were human a-globin, as determined by high performance liquid chromatography (HPLC) (Fig 1) . These mice seemed to represent a model intermediate between sickle cell trait and the disease, although closer to the former. Their RBCs were susceptible to extensive sickling when deoxygenated in vitro at physiologic conditions, but they displayed essentially normal hematologic parameters in vivo: hematocrit level, 47.2% * 2%; reticulocyte level 6.7% * 2. 13 Unlike human sickle trait, some ofthe older animals have evidence of selective organ damage." In the transgenic line used in this study, the changes in the spleen were modest.
The level of reticulocytes found in the ps transgenic mice is normal for FVB/N mice and slightly elevated for C57BL/6J mice. In addition, the CsAT (the hemoglobin concentration in equilibrium with the deoxygenated HbS polymer) of the transgenic mouse hemolysate, a measure of the solubility of deoxygenated HbS, was 28.5 f 1 g/dL, similar to that in human sickle trait." However, the elevated MCHC of the transgenic mice and the plasma osmolarity in all mice allows polymerization more readily than the CsAT would predict for an MCHC and osmolarity characteristic of humans.
Mice homozygous for the deletion of the mouse @-major globin gene and carrying a OA transgene producing 40% to 50% of the total &globin chains became normally susceptible to rodent malaria, as we have previously shown.'* Hence, they serve as a control for these studies, which show that the transgene must be os to be protective.
Mice were injected with 1 X lo6 P chabaudi adami-or 1 X 10' P berghei-infected erythrocytes. Parasitemia was monitored three times a week by making blood smears from the tail vein. The smears were stained with Giemsa, and 300 erythrocytes or 50 microscope fields at magnification of X 1,200 were examined, depending on parasite density.
Mice were anesthetized with 1 mg sodium pentobarbital (Nembutal; Abbot Laboratories, Chicago, IL) and diethyl ether. An incision was made in the left upper quadrant of the abdomen and the spleen removed after ligation ofthe splenic pedicle.
The RBCs were first deoxygenated for 24 hours in a closed capillary and then fixed in 2.5% glutaraldehyde in Infection of mice.
Splenectomy of mice.
Electron microscopy. . .
RESULTS
Five transgenic mice were injected intraperitoneally (IP) with I X IOh P cliahairdi adarni-infected erythrocytes, and the course of infection is shown in Fig 2. For comparison, we infected mice ofthe same age from the two parental inbred strains, FVB/N and C57BL/6J. A striking difference in the level and peak of parasitemia between the transgenic and control mice was observed. The results were significant on day 7 ( P < .Ol) and day 9 ( P c .05. Student's /-test). This experiment was repeated and the results showed a 2day delay and significant reduction in peak parasitemia ( P < .05).
Three transgenic and four control C57BL/6J mice were then injected IP with 5 X IO5 erythrocytes infected with the lethal strain of P hergliei. As shown in Fig 3, parasitemia was reduced in the transgenic mice, although to a lesser degree than that observed in the P chahairdi adami infection. The difference in the two groups was in the early phase of the disease and was significant on days IO and 12 (P < .02) and on day 14 (P < .05). A drop in mean parasitemia was observed on day 21 (P value not significant compared with day 19), however, because this is a lethal infection, all the mice died between days 22 and 25. This experiment was repeated and parasitemia was reduced significantly from days 7 to I I (P c .05). Again, all the mice died from infection by day 2 I.
When HbS is deoxygenated in vitro it becomes less soluble and aggregates into long polymers, deforming the RBCs into "sickle" and, more commonly, "holly leaf" shapes." In Fig  4, sickle polymers are depicted in the P herghei-infected transgenic RBCs.
The protection afforded by the presence of sickle Hb might be caused by either the inability of the parasites to grow in these erythrocytes during sequestration and/or because the infected erythrocytes expressing bs-globin are removed by the spleen before the parasite can mature in the internal organs. To investigate the role of the spleen in this model, bs transgenic as well as C57BL/6J mice were splenectomized and then infected with 1 X lo6 P chabaudi adami-infected erythrocytes. There was no significant increase in parasitemia in splenectomized compared with intact C57BL/6J mice, however, there was a recrudescence of parasitemia in the splenectomized animals (not shown). In marked contrast, splenectomy of transgenic mice expressing bs resulted in complete reversal of the protection observed in these mice (Fig 5) . The difference in parasitemia between intact and transgenic mice was highly significant from days 9 to 11 (P < .O 1). This experiment was repeated with a larger group of mice consisting of five intact and five splenectomized bs transgenics and five intact and four splenectomized CS7BL/ J, and the results were the same. The difference in parasitemia between the intact and splenectomized transgenic mice was significant from days 9 to 14 (P < .OS). One splenectomized bs transgenic mouse also recrudesced as did the splenectomized C57BL/6J mice (not shown). In summary, the intact bs transgenic mice were protected in both ofthese experiments and the splenectomized Ps mice were highly susceptible to malaria, indicating that the ps transgenic erythrocytes were fully able to support the growth of the parasite.
DISCUSSION
The coincidence of the occurrence of P falciparum, the most lethal of the human malarias, with the geographic distribution sickle Hb'33 suggests that this mutation might have been maintained in the human genome because it confers resistance against malaria to its carriers. Further epidemiologic evidence has been accumulated supporting this hyp o t h e s i~.~.~,~ In this study, we used an animal model that resembles sickle trait from the standpoint of Hb and reticulocyte levels to confirm and to extend these findings.
P chabaudi adami and P berghei are two distinct species of rodent malaria parasites.20 P chabaudi adami was discovered in the Central African Republic in the thicket rat Thamnomys rutifans. In laboratory mice, it is generally a nonlethal infection that parasitizes primarily adult RBCs. On the other hand, P berghei, which was found in Katanga (Zaire) in another thicket rat, Grammomys surdaster, is a lethal parasite in laboratory mice and infects primarily reticulocytes. Some advantages of these models are that both of these species of rodent malaria are thought to sequester to the internal organs, at least partially. On examination of tissues from infected rats, P berghei schizonts were found to sequester primarily to the bone marrow but also to the liver and spleen.2' P chabaudi binds to mouse endothelial cells in vitro22 and therefore may also sequester in vivo. On the other hand, P chabaudi adami is not lethal, whereas P falciparum is potentially lethal.
P berghei provides a model of a lethal malaria infection in mice.
Thus, it was of interest to determine whether transgenic mice expressing Ps-globin would be protected during these rodent malarial infections. Indeed, P chabaudi adami-infected mice were well protected in transgenic mice expressing human bs-globin, whereas P berghei-infected mice were protected in the initial phase of the infection. Because P chabaudi adami is a nonlethal parasite, destruction of infected erythrocytes may have a more marked effect on the course of parasitemia.
The percent of reticulocytes in the Os transgenic mice was only slightly elevated and therefore cannot account for the protection observed against P chabaudi adami, which invades primarily mature erythrocytes.
In contrast, the protection observed in the P berghei model was present in the early phase of infection, which might be important in a natural infection (induced by the bite of an infective mosquito) in which fewer merozoites might be released from hepatocytes. It is interesting to note that b-thalassemic mice were not protected from P berghei and, in fact, had a more severe course of infection than normal mice, probably because of the increase in reticulocytosis in this infection.'* Thus, the protection observed in the bs transgenic mice is quite significant. Finally, the lethality of P berghei is not fully understood. The very intense anemia observed in the latter periods of the infection suggests that, in this plasmodium, hemolysis (with or without marrow failure) might be much more significant than in human P falciparum malaria. Importantly, this model allowed us to begin to analyze the mechanism of protection in mice expressing Ps-globin in vivo.
We found that splenectomized bs transgenic mice were not protected and indeed had a more severe course of infection than intact Ps mice, whereas the difference between splenectomized and intact CS7BL/6J mice was considerably less.
The data presented here suggests that the spleen plays a dominant role in the partial innate resistance of
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mice whose erythrocytes express ,@-globin. It remains to be determined whether the effect of the spleen of the P chabaudi-infected mouse is all based on the recognition of the parasitized os transgenic erythrocytes ("suicidal infection") and/or whether there is any contribution from splenic sequestration and schizogony also leading to the death of the parasites. Such studies are in progress.
